161 related articles for article (PubMed ID: 18447755)
1. The transactivation function of the Pea3 subfamily Ets transcription factors is regulated by sumoylation.
Bojović BB; Hassell JA
DNA Cell Biol; 2008 Jun; 27(6):289-305. PubMed ID: 18447755
[TBL] [Abstract][Full Text] [Related]
2. ERM transcription factor contains an inhibitory domain which functions in sumoylation-dependent manner.
Degerny C; de Launoit Y; Baert JL
Biochim Biophys Acta; 2008 Mar; 1779(3):183-94. PubMed ID: 18243147
[TBL] [Abstract][Full Text] [Related]
3. Extracellular signal-regulated kinase mitogen-activated protein kinase signaling initiates a dynamic interplay between sumoylation and ubiquitination to regulate the activity of the transcriptional activator PEA3.
Guo B; Sharrocks AD
Mol Cell Biol; 2009 Jun; 29(11):3204-18. PubMed ID: 19307308
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning and characterization of human ERM, a new member of the Ets family closely related to mouse PEA3 and ER81 transcription factors.
Monté D; Baert JL; Defossez PA; de Launoit Y; Stéhelin D
Oncogene; 1994 May; 9(5):1397-406. PubMed ID: 8152800
[TBL] [Abstract][Full Text] [Related]
5. ERM transactivation is up-regulated by the repression of DNA binding after the PKA phosphorylation of a consensus site at the edge of the ETS domain.
Baert JL; Beaudoin C; Coutte L; de Launoit Y
J Biol Chem; 2002 Jan; 277(2):1002-12. PubMed ID: 11682477
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of the ets-related human transcription factor ER81.
Monté D; Coutte L; Baert JL; Angeli I; Stéhelin D; de Launoit Y
Oncogene; 1995 Aug; 11(4):771-9. PubMed ID: 7651741
[TBL] [Abstract][Full Text] [Related]
7. The PEA3 Ets transcription factor comprises multiple domains that regulate transactivation and DNA binding.
Bojović BB; Hassell JA
J Biol Chem; 2001 Feb; 276(6):4509-21. PubMed ID: 11096072
[TBL] [Abstract][Full Text] [Related]
8. Two functionally distinct domains responsible for transactivation by the Ets family member ERM.
Laget MP; Defossez PA; Albagli O; Baert JL; Dewitte F; Stehelin D; de Launoit Y
Oncogene; 1996 Mar; 12(6):1325-36. PubMed ID: 8649835
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.
Bossis G; Malnou CE; Farras R; Andermarcher E; Hipskind R; Rodriguez M; Schmidt D; Muller S; Jariel-Encontre I; Piechaczyk M
Mol Cell Biol; 2005 Aug; 25(16):6964-79. PubMed ID: 16055710
[TBL] [Abstract][Full Text] [Related]
10. Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains.
Kim WY; Sieweke M; Ogawa E; Wee HJ; Englmeier U; Graf T; Ito Y
EMBO J; 1999 Mar; 18(6):1609-20. PubMed ID: 10075931
[TBL] [Abstract][Full Text] [Related]
11. Divergence in regulation of the PEA3 family of ETS transcription factors.
Roussigné M; Blader P
Gene Expr Patterns; 2006 Oct; 6(8):777-82. PubMed ID: 16516559
[TBL] [Abstract][Full Text] [Related]
12. The E3 ubiquitin ligase complex component COP1 regulates PEA3 group member stability and transcriptional activity.
Baert JL; Monte D; Verreman K; Degerny C; Coutte L; de Launoit Y
Oncogene; 2010 Mar; 29(12):1810-20. PubMed ID: 20062082
[TBL] [Abstract][Full Text] [Related]
13. A functional SUMO-interacting motif in the transactivation domain of c-Myb regulates its myeloid transforming ability.
Saether T; Pattabiraman DR; Alm-Kristiansen AH; Vogt-Kielland LT; Gonda TJ; Gabrielsen OS
Oncogene; 2011 Jan; 30(2):212-22. PubMed ID: 20802522
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the human and mouse ETV1/ER81 transcription factor genes: role of the two alternatively spliced isoforms in the human.
Coutte L; Monté D; Imai K; Pouilly L; Dewitte F; Vidaud M; Adamski J; Baert JL; de Launoit Y
Oncogene; 1999 Nov; 18(46):6278-86. PubMed ID: 10597226
[TBL] [Abstract][Full Text] [Related]
15. Exon 4-encoded acidic domain in the epithelium-restricted Ets factor, ESX, confers potent transactivating capacity and binds to TATA-binding protein (TBP).
Chang CH; Scott GK; Baldwin MA; Benz CC
Oncogene; 1999 Jun; 18(25):3682-95. PubMed ID: 10391676
[TBL] [Abstract][Full Text] [Related]
16. The ETS-related transcription factor ERM is a nuclear target of signaling cascades involving MAPK and PKA.
Janknecht R; Monté D; Baert JL; de Launoit Y
Oncogene; 1996 Oct; 13(8):1745-54. PubMed ID: 8895521
[TBL] [Abstract][Full Text] [Related]
17. Solution structure of the N-terminal transactivation domain of ERM modified by SUMO-1.
Lens Z; Dewitte F; Monté D; Baert JL; Bompard C; Sénéchal M; Van Lint C; de Launoit Y; Villeret V; Verger A
Biochem Biophys Res Commun; 2010 Aug; 399(1):104-10. PubMed ID: 20647002
[TBL] [Abstract][Full Text] [Related]
18. The transcriptional repression activity of KyoT2 on the Notch/RBP-J pathway is regulated by PIAS1-catalyzed SUMOylation.
Wang J; Qin H; Liang J; Zhu Y; Liang L; Zheng M; Han H
J Mol Biol; 2007 Jun; 370(1):27-38. PubMed ID: 17509614
[TBL] [Abstract][Full Text] [Related]
19. SUMO-1 modification required for transformation by adenovirus type 5 early region 1B 55-kDa oncoprotein.
Endter C; Kzhyshkowska J; Stauber R; Dobner T
Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11312-7. PubMed ID: 11553772
[TBL] [Abstract][Full Text] [Related]
20. The Mediator complex subunit MED25 is targeted by the N-terminal transactivation domain of the PEA3 group members.
Verger A; Baert JL; Verreman K; Dewitte F; Ferreira E; Lens Z; de Launoit Y; Villeret V; Monté D
Nucleic Acids Res; 2013 May; 41(9):4847-59. PubMed ID: 23531547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
